Diane Hendricks - Net Worth and Insider Trading
Diane Hendricks Net Worth
The estimated net worth of Diane Hendricks is at least $3 Million dollars as of 2024-06-09. Diane Hendricks is the 10% Owner of Monopar Therapeutics Inc and owns about 3,524,144 shares of Monopar Therapeutics Inc (MNPR) stock worth over $3 Million. Details can be seen in Diane Hendricks's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Diane Hendricks has not made any transactions after 2019-12-18 and currently still holds the listed stock(s).
Transaction Summary of Diane Hendricks
Diane Hendricks Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Diane Hendricks owns 1 companies in total, including Monopar Therapeutics Inc (MNPR) .
Click here to see the complete history of Diane Hendricks’s form 4 insider trades.
Insider Ownership Summary of Diane Hendricks
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2019-12-18 | 10 percent owner |
Diane Hendricks Latest Holdings Summary
Diane Hendricks currently owns a total of 1 stock. Diane Hendricks owns 3,524,144 shares of Monopar Therapeutics Inc (MNPR) as of December 18, 2019, with a value of $3 Million.
Latest Holdings of Diane Hendricks
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2019-12-18 | 3,524,144 | 0.81 | 2,858,081 |
Holding Weightings of Diane Hendricks
Diane Hendricks Form 4 Trading Tracker
According to the SEC Form 4 filings, Diane Hendricks has made a total of 1 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 468,750 shares on December 18, 2019, which cost Diane Hendricks around $4 Million.
Insider Trading History of Diane Hendricks
- 1
Diane Hendricks Trading Performance
Diane Hendricks Ownership Network
Diane Hendricks Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Diane Hendricks is the 10 percent owner of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Operating Officer Andrew Cittadine , Chief Financial Officer Kim R Tsuchimoto , and director & Chief Executive Officer Chandler Robinson .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Diane Hendricks made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 60,000 shares made by Andrew Cittadine ,
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 60,000 shares, with a net purchase of 60,000 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 60,000 shares were bought by its insiders, resulting in a net purchase of 60,000 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Diane Hendricks Mailing Address
Above is the net worth, insider trading, and ownership report for Diane Hendricks. You might contact Diane Hendricks via mailing address: C/o Gem Pharmaceuticals, 200 Randolph Ave., Huntsville Al 35801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
